| Biomarkers associated with COVID-19 disease progression G Ponti, M Maccaferri, C Ruini, A Tomasi, T Ozben Critical reviews in clinical laboratory sciences 57 (6), 389-399, 2020 | 951 | 2020 |
| Microsatellite instability and colorectal cancer prognosis P Benatti, R Gafà, D Barana, M Marino, A Scarselli, M Pedroni, I Maestri, ... Clinical Cancer Research 11 (23), 8332-8340, 2005 | 458 | 2005 |
| Muir-torre syndrome G Ponti, MP de Leon The lancet oncology 6 (12), 980-987, 2005 | 320 | 2005 |
| Identification of Muir–Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry G Ponti, L Losi, C Di Gregorio, L Roncucci, M Pedroni, A Scarselli, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 165 | 2005 |
| Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry MP de Leon, M Marino, P Benatti, G Rossi, M Menigatti, M Pedroni, ... Annals of Oncology 15 (6), 940-946, 2004 | 131 | 2004 |
| Is confocal microscopy a valuable tool in diagnosing nodular lesions? A study of 140 cases C Longo, F Farnetani, S Ciardo, AM Cesinaro, E Moscarella, G Ponti, ... British Journal of Dermatology 169 (1), 58-67, 2013 | 123 | 2013 |
| Value of MLH1 and MSH2 mutations in the appearance of Muir–Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas G Ponti, L Losi, M Pedroni, E Lucci-Cordisco, C Di Gregorio, G Pellacani, ... Journal of investigative dermatology 126 (10), 2302-2307, 2006 | 110 | 2006 |
| Multiphoton laser tomography and fluorescence lifetime imaging of melanoma: morphologic features and quantitative data for sensitive and specific non-invasive diagnostics S Seidenari, F Arginelli, C Dunsby, PMW French, K König, C Magnoni, ... PLoS One 8 (7), e70682, 2013 | 91 | 2013 |
| Attenuated familial adenomatous polyposis and Muir–Torre syndrome linked to compound biallelic constitutional MYH gene mutations G Ponti, M Ponz de Leon, S Maffei, M Pedroni, L Losi, C Di Gregorio, ... Clinical genetics 68 (5), 442-447, 2005 | 91 | 2005 |
| Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes L Losi, C Di Gregorio, M Pedroni, G Ponti, L Roncucci, A Scarselli, ... Official journal of the American College of Gastroenterology| ACG 100 (10 …, 2005 | 91 | 2005 |
| Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer M Ponz de Leon, P Benatti, C Di Gregorio, M Pedroni, L Losi, M Genuardi, ... British journal of cancer 90 (4), 882-887, 2004 | 79 | 2004 |
| Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology G Ponti, M Manfredini, A Tomasi Critical reviews in oncology/hematology 141, 36-42, 2019 | 78 | 2019 |
| The value of fluorimetry (Qubit) and spectrophotometry (NanoDrop) in the quantification of cell-free DNA (cfDNA) in malignant melanoma and prostate cancer patients G Ponti, M Maccaferri, M Manfredini, S Kaleci, M Mandrioli, G Pellacani, ... Clinica Chimica Acta 479, 14-19, 2018 | 77 | 2018 |
| Cancer-associated genodermatoses: skin neoplasms as clues to hereditary tumor syndromes G Ponti, G Pellacani, S Seidenari, A Pollio, U Muscatello, A Tomasi Critical Reviews in Oncology/Hematology 85 (3), 239-256, 2013 | 75 | 2013 |
| Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome G Ponti, E Castellsagué, C Ruini, A Percesepe, A Tomasi Clinical genetics 87 (6), 507-516, 2015 | 71 | 2015 |
| Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma L Losi, G Ponti, C Di Gregorio, M Marino, G Rossi, M Pedroni, P Benatti, ... Pathology-Research and Practice 202 (9), 663-670, 2006 | 68 | 2006 |
| Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers G Ponti, G Luppi, L Losi, A Giannetti, S Seidenari Journal of hematology & oncology 3, 1-5, 2010 | 62 | 2010 |
| Multiphoton laser tomography and fluorescence lifetime imaging of basal cell carcinoma: morphologic features for non‐invasive diagnostics S Seidenari, F Arginelli, C Dunsby, P French, K König, C Magnoni, ... Experimental dermatology 21 (11), 831-836, 2012 | 60 | 2012 |
| BRAF, NRAS and C-KIT advanced melanoma: clinico-pathological features, targeted-therapy strategies and survival G Ponti, M Manfredini, S Greco, G Pellacani, R Depenni, A Tomasi, ... Anticancer research 37 (12), 7043-7048, 2017 | 58 | 2017 |
| Quantitative evaluation of healthy epidermis by means of multiphoton microscopy and fluorescence lifetime imaging microscopy E Benati, V Bellini, S Borsari, C Dunsby, C Ferrari, P French, M Guanti, ... Skin Research and Technology 17 (3), 295-303, 2011 | 56 | 2011 |
